PRNewswire

One step closer to achieving public reimbursement of AMVUTTRA® for hATTR patients in Canada MISSISSAUGA, ON, Oct. 18, 2024 /CNW/ – Alnylam Canada ULC is pleased to announce that it has signed a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public reimburs

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: